MDNC — Medinotec Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual income statement for Medinotec, fiscal year end - February 28th, USD millions except per share, conversion factor applied.
2022 February 28th | 2023 February 28th | 2024 February 29th | 2025 February 28th | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 1.04 | 1 | 5.02 | 9.11 |
| Cost of Revenue | ||||
| Gross Profit | 0.455 | 0.582 | 2.44 | 4.86 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Depreciation and Amortization | ||||
| Unusual Expense / Income | ||||
| Total Operating Expenses | 1.23 | 1.46 | 5.06 | 5.92 |
| Operating Profit | -0.191 | -0.465 | -0.041 | 3.19 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -0.189 | -0.391 | -0.254 | 3.02 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -0.124 | -0.353 | -0.405 | 2.16 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -0.124 | -0.353 | -0.405 | 2.16 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -0.124 | -0.353 | -0.405 | 2.16 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.011 | -0.03 | 0.001 | 0.184 |
| Dividends per Share |